Interventional device developer Guidant has launched the RX HercuLink Elite biliary stent system in the U.S., following Food and Drug Administration 510(k) clearance. The company also received CE Mark approval, and has begun marketing the stent system in the European Union.
RX HercuLink Elite a 0.014 rapid-exchange biliary stent system using cobalt chromium, a material that is stronger and more radiopaque than stainless steel, the Indianapolis-based company said.
The new stent system improves on the developer's previous generation of 0.014 biliary stents by increasing flexibility and radial strength, and making the stent more visible and deliverable, according to Guidant.
By AuntMinnie.com staff writers
March 10, 2006
Related Reading
Boston Scientific notifies EC of Guidant takeover, February 24, 2006
FDA completes Guidant manufacturing inspection, February 23, 2006
Guidant gets CE Mark for drug-eluting stent, February 1, 2006
Guidant sales fall in Q4, January 27, 2006
Boston Scientific raises Guidant offer, January 17, 2006
Copyright © 2006 AuntMinnie.com
